Sorrento Therapeutics Inc (SRNE)

[dia76ca]

I expect partnership(s) rather than a buyout. Within days we could hear of Chinese marketing approval for ABIVERTINIB in NSCLC and Brazilian and US EAU approval for preventing Covid cytokine storm!

On June 2, 2021 , over three months ago, Sorrento issued a press release stating, "Sorrento is seeking major global partnership(s) to co-develop and co-commercialize ABIVERTINIB." Such a partnership would presumably cover not only NSCLC and the Covid application but also many other cancers and autoimmune diseases.

ABIVERTINIB has blockbuster applications to many indications. Any partnership(s) would be worth many hundreds of millions. The worldwide Covid EUA approvals in themselves would be a game-changer! Have you ever seen a share price go down just before big news? I have!